Skip to content
10-K

Annual Report

Medicale Corp. MCLE

0001683168-26-000203

← back to feed
Filed
Jan 12, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Jan 9, 2026 5.92M sh
Shares Diluted FY 2025 · Sep 30, 2025 5.92M sh
Shares Diluted FY 2025 · Sep 30, 2024 5.92M sh
Operating Cash Flow FY 2025 · Sep 30, 2025 −$23.01K
Operating Cash Flow FY 2025 · Sep 30, 2024 −$83.59K
Stockholders Equity FY 2025 · Sep 30, 2025 −$140.09K
Stockholders Equity FY 2025 · Sep 30, 2024 −$98.93K
Stockholders Equity FY 2025 · Sep 30, 2023 −$40.72K
Current Liabilities FY 2025 · Sep 30, 2025 $33.65K
Current Liabilities FY 2025 · Sep 30, 2024 $15.51K
Total Liabilities FY 2025 · Sep 30, 2025 $140.09K
Total Liabilities FY 2025 · Sep 30, 2024 $99.09K
Current Assets FY 2025 · Sep 30, 2025 $0
Current Assets FY 2025 · Sep 30, 2024 $159
Total Assets FY 2025 · Sep 30, 2025 $0
Total Assets FY 2025 · Sep 30, 2024 $159
Eps Diluted FY 2025 · Sep 30, 2025 −$0.01
Eps Diluted FY 2025 · Sep 30, 2024 −$0.01
Eps Basic FY 2025 · Sep 30, 2025 −$0.01
Eps Basic FY 2025 · Sep 30, 2024 −$0.01
Sga Expense FY 2025 · Sep 30, 2025 $33.49K
Sga Expense FY 2025 · Sep 30, 2024 $54.71K
Net Income FY 2025 · Sep 30, 2025 −$41.15K
Net Income FY 2025 · Sep 30, 2024 −$58.21K
Operating Income FY 2025 · Sep 30, 2025 −$33.49K
Operating Income FY 2025 · Sep 30, 2024 −$54.71K